Other
Research and development expense
Johnson & Johnson Research and development expense decreased by 17.1% to $3.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $3.23B to $3.53B. Over 4 years (FY 2021 to FY 2025), Research and development expense shows relatively stable performance with a 0.7% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2007
Last reportedQ1 2026Apr 22, 2026
How to read this metric
Higher spending typically signals a commitment to long-term innovation and future product pipelines, while significant cuts may signal a shift toward short-term profitability.
Detailed definition
This metric captures the investment in creating new products, improving existing technologies, and advancing internal ca...
Peer comparison
Standard metric for technology and hardware firms; highly comparable to R&D spending at peers.
Metric ID:
other_research_and_development_expense_excluding_acquire_88a3cdHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.39B | $3.42B | $4.28B | $3.46B | $3.70B | $3.49B | $3.71B | $3.46B | $3.70B | $3.45B | $4.48B | $3.54B | $3.44B | $4.95B | $5.30B | $3.23B | $3.52B | $3.67B | $4.25B | $3.53B |
| QoQ Change | — | +0.8% | +25.2% | -19.2% | +7.0% | -5.9% | +6.5% | -6.9% | +7.2% | -6.9% | +30.0% | -20.9% | -2.9% | +44.0% | +7.0% | -39.1% | +9.0% | +4.4% | +15.8% | -17.1% |
| YoY Change | — | — | — | — | +9.1% | +1.8% | -13.4% | -0.2% | +0.0% | -1.1% | +20.8% | +2.5% | -7.1% | +43.7% | +18.3% | -8.9% | +2.2% | -25.8% | -19.7% | +9.4% |
Range$3.23B – $5.30B
CAGR+0.8%
Avg YoY Growth+2.0%
Median YoY Growth+0.9%
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Innovative Medicine | $2.55B | $2.87B | $2.94B | $3.47B | $2.81B |
| MEDTECH | $677.00M | $647.00M | $728.00M | $786.00M | $714.00M |
| Total | $3.23B | $3.52B | $3.67B | $4.25B | $3.53B |
Research and development expense at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's research and development expense?
- Johnson & Johnson (JNJ) reported research and development expense of $3.53B in Q1 2026.
- How has Johnson & Johnson's research and development expense changed year-over-year?
- Johnson & Johnson's research and development expense increased by 9.4% year-over-year, from $3.23B to $3.53B.
- What is the long-term trend for Johnson & Johnson's research and development expense?
- Over 4 years (2021 to 2025), Johnson & Johnson's research and development expense has grown at a 0.7% compound annual growth rate (CAGR), from $14.28B to $14.67B.
- What does research and development expense mean?
- Spending on innovation and product development.